Public Health articles for University of California, San Francisco (UCSF), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 14

Article ‘Count’ for Public Health.

Journal Count Share
3 1.28
The long-term impact of racial and ethnic school composition on late-life cognition, depressive symptoms, and overall health among older US Latinos 0.75
Applying mixtures methodology to analyze how exposure to structural racism and economic disadvantage affect perinatal health outcomes: an ECHO study 0.13
Evaluating administrative measures of school quality as mediators of the relationship between attending a segregated school and cognitive function among older Black individuals: the STAR study 0.40
2 1.41
Social Vulnerability and Out-of-Hospital Identification of Neurologic Emergencies 0.74
Does Exposure to Certified Stroke Centers Affect All Communities Equitably? Stroke Patient Outcomes by Community Socioeconomic Status 0.67
1 0.10
Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort. 0.10
1 0.06
Examination of Race and Ethnicity After Revascularization in the BEST-CLI Trial. 0.06
1 0.60
Systematic Review of Participant Sex, Race, and Ethnicity Reporting in Interstitial Lung Disease Clinical Trials 0.60
1 0.04
High Prevalence of Prediabetes Among Asian and Pacific Islander Adolescents With Overweight or Obesity in a Primary Care Population. 0.04
1 0.00
Social Determinants of Health and Pediatric Long COVID in the US 0.00
1 0.31
Recurrent Plasmodium falciparum Parasitemia and Drug Resistance Mutations During Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda 0.31
1 0.20
Association of a major tobacco tax increase in California with increased smoking cessation 0.20
2 0.50
From sex differences to sex inequalities in life expectancy: A cross-country observational benchmarking analysis 0.08
Dihydroartemisinin–piperaquine plus sulfadoxine–pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda 0.42

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.